RareCyte® announces the Orion™ spatial biology platform with breakthrough technology for same-day highly multiplexed tissue analysis

SEATTLE, July 16, 2020 /PRNewswire/ -- RareCyte, Inc., a company focused on providing Precision Biology™ solutions for life sciences, announced today the Orion spatial biology analysis platform applicable to translational and clinical research. Orion is based on a patented and proprietary...